scholarly article | Q13442814 |
P356 | DOI | 10.1001/ARCHINTE.157.8.913 |
P698 | PubMed publication ID | 9129552 |
P2093 | author name string | R M Philen | |
L A Love | |||
N M Sheikh | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatotoxicity | Q1349821 |
P304 | page(s) | 913-919 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | JAMA Internal Medicine | Q177428 |
P1476 | title | Chaparral-associated hepatotoxicity | |
P478 | volume | 157 |
Q34525681 | Acute liver injury associated with the use of herbal preparations containing glucosamine: three case studies |
Q35190676 | Alternative medicines and the liver |
Q37045267 | Creosote Bush (Larrea tridentata) Improves Insulin Sensitivity and Reduces Plasma and Hepatic Lipids in Hamsters Fed a High Fat and Cholesterol Diet |
Q39210610 | Creosote bush (Larrea tridentata) resin increases water demands and reduces energy availability in desert woodrats (Neotoma lepida). |
Q35808178 | Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy |
Q35606937 | Dermatologic manifestations of complementary therapy |
Q38623125 | Hepatitis associated with Kava, a herbal remedy for anxiety |
Q64227701 | Herb induced liver injury after using herbal medicine: A systemic review and case-control study |
Q26748874 | Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation |
Q39008344 | Herbal and Dietary Supplement-Induced Liver Injury |
Q35531281 | Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps |
Q38000141 | Herbal hepatotoxicity: a hidden epidemic. |
Q33927259 | Herbal hepatotoxicity: an expanding but poorly defined problem. |
Q24644452 | Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements |
Q33729545 | Making a diagnosis of herbal-related toxic hepatitis |
Q34081291 | Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update |
Q35112302 | Nordihydroguaiaretic Acid from Creosote Bush (Larrea tridentata) Mitigates 12-O-Tetradecanoylphorbol-13-Acetate-Induced Inflammatory and Oxidative Stress Responses of Tumor Promotion Cascade in Mouse Skin |
Q42106713 | Nordihydroguaiaretic acid activates hTRPA1 and modulates behavioral responses to noxious cold in mice |
Q35845214 | Phase I study of terameprocol in patients with recurrent high-grade glioma |
Q39761031 | Pyridine and pyrimidine analogs of acetaminophen as inhibitors of lipid peroxidation and cyclooxygenase and lipoxygenase catalysis. |
Q55427610 | Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016. |
Q34365919 | Review article: herbal treatment in gastrointestinal and liver disease--benefits and dangers |
Q26767376 | Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States |
Q33942079 | Should we be concerned about herbal remedies |
Q33945302 | Students investigating the antiproliferative effects of synthesized drugs on mouse mammary tumor cells |
Q31155489 | Systematic review: hepatotoxic events associated with herbal medicinal products |
Q43193383 | Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines |
Q34408281 | Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-κB-dependent transcription of TNF-α and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA. |
Q40513595 | The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice |
Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
Q43696022 | tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo |
Search more.